DOI:
10.1055/s-00030576
Revista Brasileira de Ginecologia e Obstetrícia / RBGO Gynecology and Obstetrics
LinksClose Window
References
Hill S, Khullar V, Wyndaele JJ, Lheritier K ; Darifenacin Study Group.
Dose response with darifenacin, a novel once-daily M3 selective receptor antagonist for the treatment of overactive bladder: results of a fixed dose study.
Int Urogynecol J Pelvic Floor Dysfunct 2006;
17 (3) 239-247
Search in:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.